Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | CA2 | P00918 | 4/20 | 0.38 |
| ▸ | CA9 | Q16790 | 4/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | KLK7 | P49862 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP7 | P09237 | 1/20 | 0.37 |
| ▸ | MMP10 | P09238 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | MMP13 | P45452 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 3/20 | 0.35 |
| ▸ | CA6 | P23280 | 3/20 | 0.35 |
| ▸ | CA5A | P35218 | 3/20 | 0.35 |
| ▸ | CA7 | P43166 | 3/20 | 0.35 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 6/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1872146 | 0.93 | CA12 (0.36) | CA12CA1CA2CA9CA14 | |
| SCHEMBL1868156 | 0.89 | PLA2G2A (0.33) | CA12CA1CA2CA9CA14 | |
| SCHEMBL22693647 | 0.80 | SLC29A1 (0.47) | CA12CA1CA2CA9CA14 | |
| SCHEMBL3136625 | 0.77 | KMT2A (0.55) | KMT2AKCNH3PLA2G2A | |
| SCHEMBL1873021 | 0.77 | KMT2A (0.55) | KDM4EKMT2AMEN1GAAMCL1 | |
| SCHEMBL3264001 | 0.77 | KMT2A (0.55) | KMT2AKCNH3PLA2G2A | |
| SCHEMBL721907 | 0.76 | CA12 (0.51) | CA12CA1CA2CA9CA14 | |
| SCHEMBL1870090 | 0.74 | CA1 (0.35) | CA12CA1CA2CA9CA14 | |
| SCHEMBL15402299 | 0.72 | KMT2A (0.50) | KMT2AKCNH3 | |
| SCHEMBL17089132 | 0.71 | CA1 (0.45) | CA12CA1CA2CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110105654-A1 | Method for Producing a Compound with at Least One at Least Monosubstituted Amino Group | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105654-A1 | Method for Producing a Compound with at Least One at Least Monosubstituted Amino Group | GNMT, PAM, SMOX | CA12 190/4885CA1 129/4885CA2 142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.